Search - tctmd.com

Displaying 1 - 20 of 2698

Sort: Relevancy | Date

FDA Approves Lerodalcibep for Adults With Hypercholesterolemia

News Daily News

FDA Approves Lerodalcibep for Adults With Hypercholesterolemia

Yael L. Maxwell

December 15, 2025

Uterine Fibroids Increase Future Risk of ASCVD for Up to 10 Years

News Daily News

Uterine Fibroids Increase Future Risk of ASCVD for Up to 10 Years

December 10, 2025

STAR Trial Gives Insight Into Two-Stage CTO PCI in Complex Patients

News Daily News

STAR Trial Gives Insight Into Two-Stage CTO PCI in Complex Patients

Yael L. Maxwell

December 05, 2025

Rising HF Burden in the US Potentially Related to Changes in Cardiometabolic Factors

News Daily News

Rising HF Burden in the US Potentially Related to Changes in Cardiometabolic Factors

Yael L. Maxwell

December 02, 2025

WHO Endorses Treating Obesity in Adults With GLP-1s

News Daily News

WHO Endorses Treating Obesity in Adults With GLP-1s

December 01, 2025

Asundexian Reduces Recurrent Stroke Without Bleeding Risk: OCEANIC-STROKE

News Daily News

Asundexian Reduces Recurrent Stroke Without Bleeding Risk: OCEANIC-STROKE

Michael O'Riordan

November 24, 2025

November 2025 Dispatch for the CV Team

News Opinion CV Team Dispatch

November 2025 Dispatch for the CV Team

November 24, 2025

Dig Deeper When Dealing With Nonobstructive CAD, AHA Urges

News Daily News

Dig Deeper When Dealing With Nonobstructive CAD, AHA Urges

November 21, 2025

Chronic Pain Linked to Increased Risk for Incident Hypertension

News Daily News

Chronic Pain Linked to Increased Risk for Incident Hypertension

November 20, 2025

Stress CMR Facilitates Diagnosis, Targeted Care in ANOCA: CorCMR

News Conference News AHA 2025

Stress CMR Facilitates Diagnosis, Targeted Care in ANOCA: CorCMR

November 14, 2025

POLY-HF: Polypill Pays Dividends in Patients With HFrEF

News Conference News AHA 2025

POLY-HF: Polypill Pays Dividends in Patients With HFrEF

November 14, 2025

Olezarsen Cuts Triglycerides, Pancreatitis Risk in Severe Hypertriglyceridemia

News Conference News AHA 2025

Olezarsen Cuts Triglycerides, Pancreatitis Risk in Severe Hypertriglyceridemia

Michael O'Riordan

November 14, 2025

Oral PCSK9 Inhibitor Enlicitide Cuts LDL Cholesterol: CORALreef Lipids

News Conference News AHA 2025

Oral PCSK9 Inhibitor Enlicitide Cuts LDL Cholesterol: CORALreef Lipids

Michael O'Riordan

November 10, 2025

Triple Agonist Appears Promising for Patients With Severe Hypertriglyceridemia

News Conference News AHA 2025

Triple Agonist Appears Promising for Patients With Severe Hypertriglyceridemia

November 08, 2025

Evolocumab Cuts MACE Risk in Patients Without Prior MI, Stroke: VESALIUS-CV

News Conference News AHA 2025

Evolocumab Cuts MACE Risk in Patients Without Prior MI, Stroke: VESALIUS-CV

Michael O'Riordan

November 08, 2025

CRISPR-Cas9 Gene-Editing Therapy Shows Early Promise for Dyslipidemia

News Conference News AHA 2025

CRISPR-Cas9 Gene-Editing Therapy Shows Early Promise for Dyslipidemia

November 08, 2025

At 3 Years, DCBs Still Less Safe Than DES in De Novo CAD: REC-CAGEFREE I

News Conference News TCT 2025

At 3 Years, DCBs Still Less Safe Than DES in De Novo CAD: REC-CAGEFREE I

Yael L. Maxwell

November 07, 2025

What’s Going to Be Hot at AHA 2025?

News Opinion Editor's Corner AHA 2025

What’s Going to Be Hot at AHA 2025?

Michael O'Riordan

November 05, 2025

Ultrathin-Strut DES Performs Well vs Xience in Diabetic Patients: TUXEDO-2

News Conference News TCT 2025

Ultrathin-Strut DES Performs Well vs Xience in Diabetic Patients: TUXEDO-2

November 03, 2025

News Industry News

SMT’s Supraflex Cruz Shows Consistent and Robust Clinical Outcomes Across Key Global Studies Presented at TCT 2025

October 29, 2025

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.